A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives Sodhi, M., Rezaeianzadeh, R., Kezouh, A., & Etminan, M
Silverii GA, Marinelli C, Mannucci E, Rotella F
Exemplary tumor suppressors include, but are not limited to, p53, Retinoblastoma gene (Rb), Wilm's tumor (WTl), bax alpha, interleukin-lb-converting enzyme and family, MEN-I gene, neurofibromatosis, type 1 (NFl), cdk inhibitor pi 6, colorectal cancer gene (DCC), familial adenomatosis polyposis gene (FAP), multiple tumor suppressor gene (MTS-I), BRCAl and BRCA2
This date is typically 28 days for most injectable compounded formulations, but some preparations may extend to 35 or 42 days depending on the compounding method and preservative system used